A Phase II trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancer
Phase 2
- Conditions
- ocally advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000000486
- Lead Sponsor
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Watery diarrhea 2)Use of phenytoin, warfarin potassium, or flucytosine 3)Pleural effusion or ascites 4)Active infection 5)Active concomitant malignancy 6)Active gastroduodenal ulcer 7)Severe complication, such as heart disease, renal disease, and hepatic disease 8)Severe mental disorder 9) Severe allergic reaction to drug 10)Active concomitant malignancy, pregnant and lactating females, and females of childbearing age unless using effective contraception
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method